Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System
- Resource Type
- Authors
- Debra A. Ignaut; Rong Liu; Thomas Hardy; Jennifer Boyd; Richard M. Bergenstal; Scott Morrett; Anders E. Carlson; Bruce W. Bode
- Source
- Diabetes Technology & Therapeutics. 23:828-836
- Subject
- Adult
Blood Glucose
Cross-Over Studies
Insulin Lispro
business.industry
Endocrinology, Diabetes and Metabolism
digestive, oral, and skin physiology
Insulin delivery
Similar time
Pharmacology
medicine.disease
Target range
Medical Laboratory Technology
Diabetes Mellitus, Type 1
Insulin Infusion Systems
Endocrinology
Diabetes mellitus
medicine
Humans
Hypoglycemic Agents
Insulin
business
Closed loop
Glycemic
- Language
- ISSN
- 1557-8593
1520-9156
Background: Automated insulin delivery systems are associated with improved glycemic outcomes for patients with diabetes. Ultra rapid lispro (URLi), which has an accelerated pharmacokinetic profile...